Online Sale of Medicines
Although online sales of medicines are prohibited in Russia, they account for up to 5% (73 billion rubles) of the retail segment of the local pharmaceutical market, according to estimates by the Association of Internet Trade Companies (AITC). The legalization of online sales of medicines has long been a concern for the market, causing serious disputes and heated discussions.
At the end of 2018, the AITC sent a request to Deputy Prime Minister Maxim Akimov to include the development of a draft law on online sales of non-prescription drugs in the plan of the federal project “Regulatory Control of the Digital Environment” of the state program “Digital Economy”. Large pharmacy chains have repeatedly criticized the current version of the draft law, noting that it does not address the issue of delivery, namely who will be delivering medicines – pharmacists or regular couriers.
A serious resonance in the professional community has been caused by the online retailer Ozon.ru with its home delivery of drugs. To discuss all the pros and cons of online medicine sales and find solutions to complex issues, he Kommersant Publishing House will bring together leading experts of the pharmaceutical market.
Registration, welcome coffee
- Selling medicines online: pros and cons
- The current bill on the legalization of online trading: a view from the business side
- The stumbling block: who will deliver medicines?
- Global practices in selling non-prescription drugs
- Outlook for the legalization of online sales of prescription drugs after the introduction of labeling and electronic prescriptions
- Problems of cross-border trade, or why online sales of unregistered drugs are possible and what to do about it?